Does Wegovy Cause Hair Loss?

Does Wegovy cause hair loss?

Yes, hair loss is a reported side effect of Wegovy. In the Wegovy prescribing information, hair loss was reported in 3% of people on semaglutide 2.4 mg and 1% on placebo, in trials of up to 68 weeks. The label states that these hair loss reactions were associated with weight reduction.

Zepbound's label shows a similar pattern, at 4% to 5% against 1% on placebo, and also associates its hair loss reactions with weight reduction. This page sets the labels side by side, explains what is and is not known about the cause, and lists what to bring to a prescriber.

In short

• The Wegovy label reports hair loss in 3% of people on semaglutide 2.4 mg versus 1% on placebo, in trials of up to 68 weeks.
• The Zepbound label reports 5%, 4% and 5% at 5, 10 and 15 mg versus 1% on placebo, in trials of up to 72 weeks.
• The Ozempic and Mounjaro labels list alopecia only in postmarketing reports, with no percentage given.

How common is hair loss on Wegovy and Zepbound, by the label?

The Wegovy label reports hair loss in 3% of weight-management trial patients on semaglutide 2.4 mg and 1% on placebo, and 6% on 7.2 mg. The Zepbound label reports 4% to 5% against 1%.

These rates are each label's own trial pool, in adults with obesity or overweight, for the doses and durations shown. They are not a universal rate. The Wegovy label's narrative text gives 3.3% for 2.4 mg and 5.8% for 7.2 mg, shown as 3% and 6% in its tables.

The gap over placebo is the useful comparison. For Wegovy 2.4 mg it is 3% minus 1%, or 2 percentage points. For Wegovy 7.2 mg it is 6% minus 1%, or 5 points. For Zepbound it is 5% minus 1%, or 4 points, at 5 and 15 mg, and 3 points at 10 mg.

Ozempic and Mounjaro are different. Their labels list alopecia only under postmarketing experience, not in the clinical trials table. The Ozempic label cautions that such reactions are reported voluntarily from a population of uncertain size, so it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure. Neither label gives a frequency.

Why does losing weight cause hair to fall out?

Hair loss on these medicines is most plausibly tied to weight loss and reduced intake, but no label states a drug mechanism. The Wegovy and Zepbound labels both say hair loss reactions in treated patients were associated with weight reduction.

A commonly cited explanation is telogen effluvium, a temporary shedding that can follow rapid weight loss and low intake. Treat that as a plausible explanation, not a confirmed drug mechanism.

The labels do not say:

• Whether the medicines affect hair directly, apart from the weight change.
• Whether faster weight loss means more shedding.

The trial figures cannot separate the drug from the weight change, so they describe how often hair loss was reported, not why. The labels do report differences by sex, shown in the questions below.

When does hair loss usually start, and how long does it last?

The Wegovy and Zepbound labels do not give a start time, a peak or a duration for hair loss, so none is given here. They report how many trial patients had hair loss over the whole treatment period: up to 68 weeks for Wegovy 2.4 mg, 72 weeks for Wegovy 7.2 mg and up to 72 weeks for Zepbound.

On dose, the Zepbound figures, 5%, 4% and 5%, do not rise steadily with dose. The Wegovy label lists 6% at 7.2 mg against 3% at 2.4 mg, in its 72-week 7.2 mg trials.

Medication timing is a separate question. The Zepbound label gives tirzepatide's elimination half-life as approximately 5 to 6 days, so the drug clears slowly after a last dose. For semaglutide, see a week-by-week decay table for how long semaglutide stays active. To place your own doses on that timeline, you can estimate how much semaglutide or tirzepatide is likely still active.

What helps during this kind of hair loss?

The labels do not list a treatment for hair loss, so the steps below are about context and conversation with a prescriber, not a cure. Each one rests on what the Wegovy and Zepbound labels say.

• Tell your prescriber about the shedding. The Wegovy and Zepbound labels both list hair loss as an adverse reaction, so it is a known report your prescriber can weigh.
• Share how you are eating. The Wegovy label links hair loss to weight reduction, and low intake is a commonly discussed contributor, so your intake is useful context. This is not a calorie or protein target.
• Keep a record. Note when shedding began, your doses and your weight changes, so a pattern can be shown rather than remembered.
• Check before adding products. This page makes no supplement claims, and the labels give none.
• Ask your prescriber if it does not ease. Any decision about your dose or medicine is theirs to make with you. Do not change, skip or stop a dose because of shedding.

When does hair loss need a doctor's attention?

The Wegovy and Zepbound labels set no hair loss threshold for urgent care, so mention shedding to your prescriber, and seek care at once for the label's warning signs below. These are not signs of hair loss. They are serious conditions listed in the Wegovy label's warnings and precautions.

• Thyroid tumor signs: a neck mass, trouble swallowing, trouble breathing or persistent hoarseness.
• Pancreatitis: persistent or severe abdominal pain, sometimes radiating to the back.
• Severe allergic reaction: swelling of the face, lips, tongue or throat, or trouble breathing.
• Increased resting heart rate: palpitations or a racing heartbeat at rest.

If any of these appear, contact a doctor or emergency services without waiting.

How can you log hair shedding next to doses and weight?

Dose & Lose is a tracking app for iPhone and Android that lets you keep a day-by-day record to show a prescriber. You log each dose, rate symptoms from 0 to 10 and add notes, so hair shedding can be written in beside the dose it followed. You can also log protein and weight.

It does not diagnose, measure or treat hair loss, and it gives no dosing advice. You can log side effects like hair shedding alongside doses, protein and weight and bring the record to your appointment.

Frequently asked questions

Does hair grow back after stopping a GLP-1 medicine?

The labels do not say whether hair grows back. They report hair loss during treatment and a short off-drug follow-up of 7 weeks for Wegovy and 4 weeks for Zepbound, without regrowth figures. A prescriber can judge your own situation and discuss next steps.

Is hair loss worse at higher doses?

On Wegovy, the label reports more hair loss at 7.2 mg than at 2.4 mg: 6% versus 3%, against 1% on placebo, in two 72-week trials. Zepbound's 5%, 4% and 5% at 5, 10 and 15 mg do not rise steadily. Dose decisions belong to your prescriber.

Is hair loss more common in women than men on these medicines?

Yes, both labels report hair loss more often in women. On Wegovy 2.4 mg, 4% of females and 0.9% of males, against 2% and 0% on placebo, in trials of up to 68 weeks. On Zepbound, 7.1% of females and 0.5% of males, against 1.3% and 0% on placebo, in trials of up to 72 weeks. A prescriber can discuss individual risk.

Can protein intake affect hair shedding during weight loss?

The labels do not report protein as a way to prevent hair loss, so no label figure answers this. The Wegovy label links hair loss to weight reduction, and low intake is a commonly discussed contributor. Logging protein can give your prescriber context, but it is not a treatment.

Sources

• Wegovy prescribing information, DailyMed: hair loss rates by dose and sex, trial duration, weight-reduction statement, warnings.
• Zepbound prescribing information, DailyMed: hair loss by dose and sex, trial duration, half-life.
• Ozempic prescribing information, DailyMed: postmarketing alopecia listing and its caveat.
• Mounjaro prescribing information, DailyMed: postmarketing alopecia listing.

Published by Petros IT Solutions SRL, written by the Dose & Lose Editorial Team. Corrections: office@doseandlose.com.